Why Your 340B Hospital Can and Should Have an Onsite Specialty Pharmacy An onsite specialty pharmacy benefits your hospital’s patients by – Ensuring that oversight
According to a 2018 study conducted by the National Institutes Of Health (NIH), the average cost of a patient readmission is $15,200. It’s been estimated that
Just as a skilled pharmacist meticulously tailors each prescription to achieve the perfect therapeutic outcome, ProxsysRx fine-tunes a 340B savings strategy to deliver optimal results.
Product & Service Providers in: MANUFACTURING: 503B Outsourcing Facilities, Compounding Services DISTRIBUTION: 340B Solutions, Management Systems COMPOUNDING: Sterile Compounding, IV Automation PATIENT CARE: Adherence, Compliance As Seen In: View
BIRMINGHAM, AL — August 22, 2024 — ProxsysRx has opened its newest retail pharmacy for Yuma Regional Medical Center (YRMC), a 430-bed, not-for-profit hospital with
Click either link above to download ProxsysRx’s resource guide, available in Desktop and Mobile versions. Far too many 340B hospitals overlook pharmacy’s overall potential in their
South Carolina’s Conway Medical Center (CMC), a 210-bed private non-profit acute care hospital with more than 1600 employees, is now the fifth hospital for whom
ProxsysRx has generated more than $500 million in 340B savings for health systems we serve, overcoming restrictions that have devasted so many other hospital programs.
Why Your 340B Hospital Can And Should Have An Onsite Specialty Pharmacy An onsite specialty pharmacy benefits your hospital’s patients by: – Ensuring that oversight
The automated approach to optimizing 340B savings & patient care while overcoming manufacturer restrictions ProxsysRx’s 340B Team has generated more than $500 million in savings
